Basilea Pharmaceutica AG (SWX: BSLN)
Switzerland
· Delayed Price · Currency is CHF
40.55
+0.20 (0.50%)
Nov 21, 2024, 5:31 PM CET
Basilea Pharmaceutica AG Market Cap
Basilea Pharmaceutica AG has a market cap or net worth of 491.51 million as of November 22, 2024. Its market cap has increased by 15.41% in one year.
Market Cap
491.51M
Enterprise Value
541.00M
Revenue
149.02M
Ranking
n/a
PE Ratio
n/a
Stock Price
40.55
Market Cap Chart
Since March 25, 2004, Basilea Pharmaceutica AG's market cap has decreased from 533.29M to 491.51M, a decrease of -7.83%. That is a compound annual growth rate of -0.39%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 200.18B |
Roche Holding AG | 200.18B |
Novartis AG | 181.91B |
Lonza Group AG | 37.34B |
Alcon Inc. | 37.30B |
Galderma Group AG | 20.42B |
Sonova Holding AG | 17.91B |
Straumann Holding AG | 17.59B |